Difference between revisions of "Adopt Universal Screening for Pregnant People"

From SAFE Solutions
Jump to navigation Jump to search
user>Pkalch
user>Mredden
Line 1: Line 1:
<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
<div class="wiki" id="content_view" style="display: block">
Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]
Return to&nbsp; [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]


__TOC__
__TOC__


<br/> Another potential strategy is to universally screen all pregnant women for substance abuse. In Kaiser Permanente's [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start ]program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.<sup class="reference">[1]</sup><br/> <br/> '''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women] - Kaiser Permanente'''<br/> ''Overview of program'':
= <br/> Overview =
 
Another potential strategy is to universally screen all pregnant women for substance abuse.
 
= Key Information =
 
= Relevant Research =
 
&nbsp;In Kaiser Permanente's [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start ]program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.<sup class="reference">[1]</sup><br/> <br/> '''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057720/ Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women] - Kaiser Permanente'''<br/> ''Overview of program'':


*Universally screen all pregnant women  
*Universally screen all pregnant women  
Line 17: Line 25:
*Reduces all barriers to care, including in prenatal care  
*Reduces all barriers to care, including in prenatal care  


<br/> '''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':
'''[http://www.ajog.org/article/S0002-9378(16)30383-0/fulltext#tbl4 The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS]'''<br/> ''Method'':


''Screening Instruments:''
''Screening Instruments:''
Line 34: Line 42:
*Urine toxicology should not be used in place of screening  
*Urine toxicology should not be used in place of screening  


&nbsp;
= Impactful Federal, State, and Local Policies =


= Promising Practices for Standardized Screening =
= Promising Practices for Standardized Screening =
Line 43: Line 51:


&nbsp; To understand and address perinatal substance use, accurate data needed to be collected through '''standardized screening and testing:'''
&nbsp; To understand and address perinatal substance use, accurate data needed to be collected through '''standardized screening and testing:'''
&nbsp;


*When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.  
*When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.  
Line 52: Line 58:
*Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.  
*Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.  


<br/> ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''<br/> &nbsp;
ISDH noted that universal screening in a [[Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|non-punitive]] environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.<sup class="reference">[2]</sup><br/> <br/> ''See [[Improve_Identifying_and_Data_Collection_on_NAS|Improve Identifying and Data Collecting on NAS]] for more information on defining, testing, and reporting data about NAS.''


= Tools & Resources =
= Available Tools and&nbsp;Resources =


[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]
[[TR_-_Adopt_Universal_Screening_for_Pregnant_Women|TR - Adopt Universal Screening for Pregnant Women]]


{| class="wiki_table"
= &nbsp; =
|-
| '''Reviewer'''
| '''Date'''
| '''Comments'''
|-
| &nbsp;
| &nbsp;
| &nbsp;
|}


= Sources =
&nbsp;


----
----
Sources


#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]  
#[http://onlinelibrary.wiley.com/doi/10.1111/1552-6909.12531/full [1]]  
#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]  
#[http://www.amchp.org/programsandtopics/BestPractices/InnovationStation/ISDocs/Perinatal%20Substance%20Use.pdf [2]]  
</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
</div>
[[Category:SAFE-Full Spectrum Prevention]]
[[Category:SAFE-Full Spectrum Prevention]]

Revision as of 08:27, 8 February 2021

Return to  ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use


Overview

Another potential strategy is to universally screen all pregnant women for substance abuse.

Key Information

Relevant Research

 In Kaiser Permanente's Early Start program, pregnant women were screened for substance abuse risk at the first prenatal visit by a self-administered questionnaire and by urine toxicology testing (with signed consent). Universal screening facilitates early identification and treatment of substance use.[1]

Early Start: An Integrated Model of Substance Abuse Intervention for Pregnant Women - Kaiser Permanente
Overview of program:

  • Universally screen all pregnant women
  • No mandated reporting for toxicology
  • Mental health provider apart of obstetric care
  • Use video conferencing and telephone to provide care to immediate and remote care

Outcome Successes:

  • Show decrease in morbidity for mothers and babies
  • Cost beneficial
  • Reduces all barriers to care, including in prenatal care

The role of screening, brief intervention, and referral to treatment in the perinatal period -- Tricia E. Wright, MD, MS
Method:

Screening Instruments:

  • CAGE -- Cut down, Annoyed, Guilt, Eye opener
  • T-ACE -- Takes, Annoyed, Cut down, Eye opener
  • TWEAK -- Tolerance, Worry, Eye opener, Amnesia, Cut down
  • 4Ps -- Past, Present, Parents, Partner
  • NIDA Quick Screen -- Uses 3 open-ended questions regarding alcohol, tobacco, and other drugs

Key Screening Conclusions:

  • Screening should be done for all pregnant women and throughout pregnancy for those at risk
  • Screening can be done by a provider using a validated instrument during follow-up or by asking standardized questions during interview
  • Screening must be nonjudgemental and open-ended
  • Urine toxicology should not be used in place of screening

Impactful Federal, State, and Local Policies

Promising Practices for Standardized Screening

Indiana State Department of Health

In 2014, because of the high rate of opioid prescriptions, the Indiana General Assembly charged the Indiana State Department of Health (ISDH) to: develop a standard clinical definition of NAS and a standardized process of identifying it, identify the resources hospitals need to do this, and then establish a voluntary pilot program with hospitals to implement this standardized NAS identification. As of 2016, 26 of 89 Indiana Birthing Hospitals are taking part in this pilot screening program

  To understand and address perinatal substance use, accurate data needed to be collected through standardized screening and testing:

  • When any pregnant arrives at the hospital for delivery, hospital personnel conduct a standardized and validated verbal screening regarding substance use.
  • Any woman with a positive verbal screen at any point during pregnancy, including at presentation for delivery, is requested to consent to a urine toxicology screening.
  • Babies whose mothers had a positive verbal screen or toxicology screen, or babies whose mothers did not consent to the toxicology screen will be tested for evidence of maternal substance use using the infant’s umbilical cord.
    • Note: Umbilical cord testing, not meconium stool, was used on all infants.
  • Babies also have modified Finnegan scoring initiated to observe for signs and symptoms of NAS.

ISDH noted that universal screening in a non-punitive environment would allow us to understand the true prevalence of Perinatal Substance Use and NAS.[2]

See Improve Identifying and Data Collecting on NAS for more information on defining, testing, and reporting data about NAS.

Available Tools and Resources

TR - Adopt Universal Screening for Pregnant Women

 

 


Sources

  1. [1]
  2. [2]